These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 25888213)

  • 1. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
    Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
    BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy.
    Selmer R; Haglund B; Furu K; Andersen M; Nørgaard M; Zoëga H; Kieler H
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1160-1169. PubMed ID: 27193296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
    Kieler H; Artama M; Engeland A; Ericsson O; Furu K; Gissler M; Nielsen RB; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B
    BMJ; 2012 Jan; 344():d8012. PubMed ID: 22240235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
    Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
    JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
    Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
    N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant use in pregnancy and the risk of cardiac defects.
    Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S
    N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
    Alwan S; Reefhuis J; Rasmussen SA; Olney RS; Friedman JM;
    N Engl J Med; 2007 Jun; 356(26):2684-92. PubMed ID: 17596602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
    Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
    JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
    Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
    BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.
    Reefhuis J; Devine O; Friedman JM; Louik C; Honein MA;
    BMJ; 2015 Jul; 351():h3190. PubMed ID: 26156519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
    Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
    PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
    Pedersen LH; Henriksen TB; Vestergaard M; Olsen J; Bech BH
    BMJ; 2009 Sep; 339():b3569. PubMed ID: 19776103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
    Einarson A; Fatoye B; Sarkar M; Lavigne SV; Brochu J; Chambers C; Mastroiacovo P; Addis A; Matsui D; Schuler L; Einarson TR; Koren G
    Am J Psychiatry; 2001 Oct; 158(10):1728-30. PubMed ID: 11579012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.
    Nezvalová-Henriksen K; Spigset O; Brandlistuen RE; Ystrom E; Koren G; Nordeng H
    Int J Epidemiol; 2016 Dec; 45(6):2018-2029. PubMed ID: 27188860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
    Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks associated with selective serotonin reuptake inhibitors in pregnancy.
    Malm H; Klaukka T; Neuvonen PJ
    Obstet Gynecol; 2005 Dec; 106(6):1289-96. PubMed ID: 16319254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD.
    Margulis AV; Abou-Ali A; Strazzeri MM; Ding Y; Kuyateh F; Frimpong EY; Levenson MS; Hammad TA
    Pharmacoepidemiol Drug Saf; 2013 Sep; 22(9):942-51. PubMed ID: 23733623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage.
    Andersen JT; Andersen NL; Horwitz H; Poulsen HE; Jimenez-Solem E
    Obstet Gynecol; 2014 Oct; 124(4):655-661. PubMed ID: 25198261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.